ORBIMED ADVISORS LLC – Aclaris Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$43.41M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.62% | 432.93K shares | 10.95M | $15.74 | 2.75M |
| Q2 2022 | share | Increase | +47.19% | 745.6K shares | 5.22M | $13.96 | 2.32M |
| Q1 2022 | share | Increase | +60.25% | 594K shares | 12.90M | $17.24 | 1.57M |
| Q4 2021 | share | Increase | +51.26% | 334.11K shares | 2.60M | $14.33 | 985.9K |
| Q3 2021 | share | Increase | +80.05% | 289.78K shares | 5.37M | $18 | 651.78K |
| Q2 2021 | share | Increase | 0.00% | 362K shares | 6.35M | $17.56 | 362K |